Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease

OBJECTIVE: Heparanase (HPA), mammalian endo-β-D-glu­cu­ronidase, separates heparan sulfate chains of proteoglycans and changes the structure of the extracellular matrix. We investigated whether serum levels of HPA differ in patients with stable coronary artery disease (SCAD) and subjects with normal...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Med Princ Pract
Auteurs principaux: Gurbuz, Ahmet Seyfeddin, Ozturk, Semi, Efe, Suleyman Cagan, Yilmaz, Mehmet Fatih, Yanik, Raziye Ecem, Yaman, Ali, Kirma, Cevat
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2019
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944950/
https://ncbi.nlm.nih.gov/pubmed/31480068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503085
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires